1. Home
  2. LWAC vs TNYA Comparison

LWAC vs TNYA Comparison

Compare LWAC & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LWAC
  • TNYA
  • Stock Information
  • Founded
  • LWAC 2025
  • TNYA 2016
  • Country
  • LWAC United States
  • TNYA United States
  • Employees
  • LWAC N/A
  • TNYA N/A
  • Industry
  • LWAC
  • TNYA Medicinal Chemicals and Botanical Products
  • Sector
  • LWAC
  • TNYA Health Care
  • Exchange
  • LWAC Nasdaq
  • TNYA Nasdaq
  • Market Cap
  • LWAC 301.1M
  • TNYA 326.0M
  • IPO Year
  • LWAC 2025
  • TNYA 2021
  • Fundamental
  • Price
  • LWAC $10.03
  • TNYA $1.61
  • Analyst Decision
  • LWAC
  • TNYA Strong Buy
  • Analyst Count
  • LWAC 0
  • TNYA 5
  • Target Price
  • LWAC N/A
  • TNYA $8.60
  • AVG Volume (30 Days)
  • LWAC 72.2K
  • TNYA 4.7M
  • Earning Date
  • LWAC 01-01-0001
  • TNYA 11-06-2025
  • Dividend Yield
  • LWAC N/A
  • TNYA N/A
  • EPS Growth
  • LWAC N/A
  • TNYA N/A
  • EPS
  • LWAC N/A
  • TNYA N/A
  • Revenue
  • LWAC N/A
  • TNYA N/A
  • Revenue This Year
  • LWAC N/A
  • TNYA N/A
  • Revenue Next Year
  • LWAC N/A
  • TNYA N/A
  • P/E Ratio
  • LWAC N/A
  • TNYA N/A
  • Revenue Growth
  • LWAC N/A
  • TNYA N/A
  • 52 Week Low
  • LWAC $9.81
  • TNYA $0.36
  • 52 Week High
  • LWAC $10.05
  • TNYA $4.01
  • Technical
  • Relative Strength Index (RSI)
  • LWAC N/A
  • TNYA 47.03
  • Support Level
  • LWAC N/A
  • TNYA $1.55
  • Resistance Level
  • LWAC N/A
  • TNYA $2.02
  • Average True Range (ATR)
  • LWAC 0.00
  • TNYA 0.16
  • MACD
  • LWAC 0.00
  • TNYA -0.06
  • Stochastic Oscillator
  • LWAC 0.00
  • TNYA 9.38

About LWAC LightWave Acquisition Corp. Class A Ordinary Shares

LightWave Acquisition Corp is a blank check company.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.

Share on Social Networks: